Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
VELTI PLC OR VELT
7.58%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%

Merge Expands with iConnect

by Zacks Equity Research

April 11, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Enterprise imaging and interoperability solutions provider Merge Healthcare ( MRGE - Analyst Report ) recently extended its existing relationship with Mercy, the 8th major Catholic health care system in the US, through a new deal. As per the new deal, Mercy will adopt Merge’s vendor neutral archive iConnect VNA to serve its enterprise of over 200 clinics and hospitals in the midwest. However, financial terms of the deal were not disclosed.

The recent deal enables Mercy to meet the ‘Meaningful Use’ needs of imaging interoperability and provide better service to more than 3 million people per year.

Presently, used at more than 300 sites, Merge's iConnect VNA is the most widely deployed vendor neutral archive in the healthcare industry. In addition to this, the Merge iConnect Suite also includes iConnect Share and iConnect Access. With greater adoption of electronic health records (EHR) in doctor’s offices, hospitals and imaging centers, the smooth exchange of data becomes essential. Under this circumstance, Merge’s iConnect platform has gained significance as it is a vendor-neutral archive.

Currently, imaging in laboratories accounts for over 90% of data storage in healthcare. According to Frost and Sullivan and Merge’s recent research reports, the global market for imaging software and services, healthcare IT interoperability solutions and electronic health records (EHR) solutions for radiology, cardiology, ophthalmology and orthopedics is worth $7.5 billion annually. With greater adoption of EHRs in doctor’s offices, hospitals and imaging centers, there is a consequent increase in the need for data exchange.

We also believe that Merge possesses strong growth potential in the Radiology Information System/ Picture Archiving and Communication System (RIS/PACS) market. There is immense potential in the diagnostic imaging market, especially with the government’s emphasis on health IT (HIT) and an ageing population.

According to the Centers for Medicare and Medicaid Services (CMS), through December 2011, more than 175,000 professionals and hospitals were registered for meaningful use incentive programs and $2.5 billion was paid out in 2011 to eligible hospitals and professionals. The incentives will be offered for a period of 4-5 years, after which physicians will be penalized for not adopting proper measures. The incentive aims to enhance the use of EHR by medical practitioners, in both ambulatory and hospital-based settings.

However, we remain concerned about the declining Medicare reimbursement for advanced medical imaging that could negatively affect hospital and imaging clinic revenues, thereby reducing the demand for imaging-related software and services offered by Merge. Furthermore, the presence of many big players like General Electric ( GE - Analyst Report ) and McKesson Corporation ( MCK - Analyst Report ) has made the healthcare solutions and services market highly competitive.

Presently, Merge retains a short-term Zacks #2 Rank (Buy). Over the long term, we have a ‘Neutral’ recommendation on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.